Nilmarie Ayala-Fontánez,David C Soler,Thomas S McCormick
Nilmarie Ayala-Fontánez
Psoriasis is a prevalent, chronic inflammatory disease of the skin, mediated by crosstalk between epidermal keratinocytes, dermal vascular cells, and immunocytes such as antigen presenting cells (APCs) and T cells. Exclusive cellular "respo...
Integrating lifestyle-focused approaches into psoriasis care: improving patient outcomes? [0.03%]
以生活方式为导向的银屑病综合管理：改善患者预后的效果如何？
Angelo Landriscina,Adam J Friedman
Angelo Landriscina
Psoriasis is one of the most well described cutaneous disorders, with a large body of literature devoted to describing its pathogenesis and treatment. In recent years, attention has turned toward the mechanisms by which lifestyle can impact...
Aikaterini I Liakou,Christos C Zouboulis
Aikaterini I Liakou
Introduction: Psoriasis has long been considered a systemic inflammatory disease. Lately, it has been strongly associated with obesity, as well as other components of metabolic syndrome, such as dyslipidemia, insulin resi...
Update on the treatment of psoriasis and psoriatic arthritis - role of apremilast [0.03%]
银屑病和银屑病关节炎的治疗进展——阿普斯特的作用
Stephan Forchhammer,Kamran Ghoreschi
Stephan Forchhammer
Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis (PsO). The treatment of PsA can be challenging and includes non-steroidal anti-inflammatory drugs, synthetic disease modifying antirheumatic drugs, and biologi...
Improving patient outcomes in psoriasis: strategies to ensure treatment adherence [0.03%]
改善银屑病患者预后的策略：确保治疗依从性
Oriol Yélamos,Sandra Ros,Lluís Puig
Oriol Yélamos
Psoriasis is a frequent inflammatory disease with a chronic and relapsing course. Therefore, patients with psoriasis are likely to undergo different treatments for long periods of time. Traditionally, therapies used in psoriasis have been a...
Calcipotriol/betamethasone for the treatment of psoriasis: efficacy, safety, and patient acceptability [0.03%]
卡泊三醇/倍他米松治疗银屑病的疗效、安全性及患者依从性研究
Christina Rogalski
Christina Rogalski
Background: One of the advances in the treatment of plaque-type psoriasis is combined local therapy with calcipotriol and betamethasone. To provide both ingredients in a two-compound product, efforts have been made to uni...
Gino Antonio Vena,Nicoletta Cassano,Gilberto Bellia et al.
Gino Antonio Vena et al.
The available information about the effects of pregnancy on psoriasis and those of psoriasis on pregnancy is almost limited, despite the high frequency of the disease in the general population, as well as in women in reproductive years. Con...
Assessing the effectiveness of synthetic and biologic disease-modifying antirheumatic drugs in psoriatic arthritis - a systematic review [0.03%]
评估银屑病关节炎患者使用合成和生物反应修饰抗风湿药的有效性——系统评价
Gabrielle H Kingsley,David L Scott
Gabrielle H Kingsley
Background: Psoriatic arthritis is an inflammatory arthritis the primary manifestations of which are locomotor and skin disease. Although a number of guidelines have been published citing strategies for reducing disease p...
Subcutaneous methotrexate for symptomatic control of severe recalcitrant psoriasis: safety, efficacy, and patient acceptability [0.03%]
皮下注射甲氨蝶呤治疗严重难治性银屑病：安全性、有效性和患者可接受度
Iviensan F Manalo,Kathleen E Gilbert,Jashin J Wu
Iviensan F Manalo
Background: Although oral methotrexate is an effective first-line traditional systemic therapy for psoriasis, the use of the subcutaneous form of methotrexate for the treatment of psoriasis has not been fully established....
Gleison V Duarte,Larissa Porto-Silva,Maria de Fátima Paim de Oliveira
Gleison V Duarte
Psoriasis is a chronic immune-mediated systemic disease that is influenced by genetic and environmental factors, is associated with comorbidities, and has a negative impact on the quality of life of affected individuals. The prevalence of p...